AlloSource is the lead sponsor of 6 current clinical trials in our USA register. 2 are recruiting patients now. The most common phase is Observational. The most-studied condition is Pre-Pectoral Breast Reconstruction Following Single or Double Mastectomy.
| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
AlloMend Acellular Dermal Matrix Allograft in Pre-Pectoral Breast Reconstruction
NCT06512259 · Pre-Pectoral Breast Reconstruction Following Single or Double Mastectomy
|
Observational | Recruiting | 2023-10 | USA |
|
Evaluating Cryopreserved Osteochondral Allograft Cores for the Treatment of Osteochondral Lesions in the Knee
NCT06216756 · ClinicalTrials.gov ↗ · Osteochondral Defect
|
Not applicable | Recruiting | 2024-12 | USA |
|
Effectiveness of AlloWrap® for the Reduction of Inflammation in ACDF Procedures
NCT04684901 · ClinicalTrials.gov ↗ · Cervical Stenosis, Spondylolisthesis, Cervical Radiculopathy
|
Not applicable | By invitation | 2021-01 | USA |
|
Prospective Evaluation of ProChondrix CR for Repair of Articular Cartilage Defects on Femoral Condyle and Patella
NCT03873545 · ClinicalTrials.gov ↗ · Cartilage Injury, Cartilage Damage
|
Observational | Active, closed | 2019-03 | USA |
|
Retrospective Study of AlloMend Acellular Dermal Matrix (ADM) Allograft and Pre-Pectoral Breast Reconstruction
NCT06853964 · ClinicalTrials.gov ↗ · Pre-Pectoral Breast Reconstruction Following Mastectomy
|
Observational | Active, closed | 2025-01 | USA |
|
Histological Analysis of AlloMend® Acellular Dermal Matrix Used in Breast Implant Surgeries
NCT05744414 · ClinicalTrials.gov ↗ · Breast Implant; Complications, Infection or Inflammation
|
Observational | Active, closed | 2023-05 | USA |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in USA | 6 | 2 |
A trial with sites in more than one country appears in each of those registers.
AlloSource is the lead sponsor of 6 current trials on ClinicalTrials.gov in our USA register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Yes. 2 of its 6 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.